Jordan underlines reputation as MENA region's leading medical tourism hub with over 224,000 international visitations in 2024
The Jordan Tourism Board (JTB) highlighted the country's growing reputation as a premier medical and wellness tourism destination in the Middle East and North Africa region reporting significant growth in international visitations for medical care and wellness therapies. The country's medical tourism sector witnessed a remarkable increase with 224,740 medical tourists in 2024, building on consistent growth from 191,532 in 2022 and 202,592 in 2023. The first quarter of 2025 has already recorded 51,448 medical tourists, underlining another strong year for the sector. Jordan's comprehensive healthcare ecosystem, comprising 69 private sector hospitals with approximately 5,500 beds, has positioned the country as a preferred destination for patients seeking advanced medical treatments, particularly from GCC nations and neighboring countries.
'Jordan's medical tourism sector has demonstrated remarkable growth, led by theworld-class healthcare services the country offers, the natural therapeutic sites with first class resorts, and our famed hospitality,' said Dr. Abdelrazzak Arabiyat, Managing Director of the Jordan Tourism Board. 'Our healthcare facilities maintain international standards while providing cost-effective treatments, making Jordan an attractive destination for patients seeking high quality medical care.'
Jordan's strong position in regional medical tourism is highlighted by Iraq leading international demand at 257,396 visitations, followed by Saudi Arabia (216,256) seeking both inpatient and outpatient services. More than 31,920 visitors from Kuwait arrived in Jordan for medical tourism followed by Qatar at 15,524, Bahrain (13,856), Oman (8,828), and the UAE (6,584).
GCC visitors particularly value Jordan's cultural resonance, shared language, and understanding of their healthcare preferences. Recent studies show that Saudi and Kuwaiti patients primarily seek comprehensive diagnostic tests, weight loss surgeries, advanced dental care, and cosmetic dermatology.
Omani visitors showed strong interest in vision correction and eye health treatments, while Bahraini patients prefer to pursue cosmetic and orthopedic treatments. The presence of female healthcare professionals, prayer facilities, and halal dining options further enhances the appeal for GCC patients and their families.
'The diversity of medical specialties available in Jordan, combined with the expertise of our healthcare professionals, who are trusted across the GCC, has created a strong medical tourism ecosystem,' added Dr. Arabiyat. 'The visitors are further energised by the natural therapeutic destinations that add to the well-being of all visitors.'
Natural therapeutic Destinations
Jordan's geographic features provide natural therapeutic sites that complement the country's advanced medical facilities. The Dead Sea, 400 meters below sea level, offers exceptional therapeutic benefits through its mineral-rich waters containing 33% salt content and high levels of magnesium, sodium, and bromine. These properties have proven beneficial for treating various skin conditions, respiratory issues, and rheumatic diseases.
The country's atmospheric conditions, including year-round UVB radiation filtered by an extra atmospheric layer, increased oxygen content, and minimal pollution, also contribute to an optimal environment for health treatments. These advantages have attracted wellness seekers for centuries and continue to draw medical tourists seeking both traditional and modern therapeutic treatments.
The country's wellness offerings span from Dead Sea spa treatments featuring mineral-rich mud therapy to the therapeutic waters of Ma'in Hot Springs, where mineral-rich waters reach temperatures of 63°C. Visitors can experience traditional Arabian Hammam treatments alongside modern rehabilitation therapies. Several luxury wellness resorts offer specialied programs that combine natural healing with contemporary medical approaches.
Infrastructure and Accessibility
Jordan's medical tourism infrastructure is supported by state-of-the-art facilities and advanced medical technology. The healthcare sector has made significant investments in modern equipment and specialized units, ensuring international standards of patient care and better outcomes.
The country's strategic location and excellent air connectivity make it easily accessible for international visitors, with flight times averaging 2-3 hours from major Gulf cities. Multiple daily flights operate from key GCC destinations, facilitating convenient travel for both patients and their families. For more information about medical tourism in Jordan, visit www.visitjordan.com
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Web Release
4 days ago
- Web Release
SGH achieves remarkable milestone: Five hospitals granted 5-star rating by Newsweek's Global Hospital Rating
Saudi German Health (SGH), a leading healthcare group in the Middle East and North Africa (MENA) region, has reinforced its industry leadership with five of its hospitals in Saudi Arabia earning five-star ratings in Newsweek's Global Hospital Rating. The hospitals in Riyadh, Makkah, Madinah, Aseer, and Jeddah all received this rating, establishing SGH as the healthcare group with the most five-star-rated hospitals in the region. This latest milestone reinforces SGH's unwavering commitment to providing top-patient-centred healthcare, while upholding high clinical standards and embracing innovative healthcare solutions. It also reflects SGH's ongoing efforts to align with Saudi Arabia's ambitious Vision 2030 goals, which aim to improve quality of life and elevate the Kingdom's healthcare sector to global standards. Makarem Sobhi Batterjee, Vice Chairman of Saudi German Health, said: 'We are proud to be recognised once again as the healthcare group with the highest number of five-star-rated hospitals in the region. This achievement is a testament to our dedication to clinical excellence, innovation, and exceptional service. It is not the first time we lead the region with such accomplishments — earlier this year, we were also honoured with having the highest number of top-ranked hospitals in the region in Newsweek's World's Best Hospitals 2025 list. These achievements reflect our strong leadership, our proud Saudi identity, and our alignment with Vision 2030's healthcare transformation goals.' These recognitions by Newsweek emphasise SGH's role as a pioneer of healthcare excellence in the Kingdom and the wider region. By consistently meeting the highest international standards and achieving outstanding results, Saudi German Health continues to influence the future of healthcare across Saudi Arabia and beyond.
Zawya
17-07-2025
- Zawya
KFSHRC performs world's first robotic-assisted BiVAD Implantation
A minimally invasive robotic surgery offers a life-saving option for high-risk patients who cannot undergo transplants or traditional open-heart procedures King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully performed the world's first implantation of two artificial pumps for biventricular support (BiVAD-HMIII) using robotic technology on a patient with advanced heart failure. This groundbreaking procedure opens new horizons in circulatory support techniques for patients with complex cardiac conditions and marks a medical achievement that culminated in the patient's recovery within a short period following the surgery. The procedure represents a major advancement in the treatment of bilateral heart failure, which was traditionally performed through full sternotomy, an approach associated with higher surgical risks and prolonged recovery. However, the cardiac surgery team at KFSHRC, led by Prof. Feras Khaliel, successfully performed the operation through small incisions using remotely controlled high-precision robotic arms, resulting in reduced blood loss, lower risk of infection, and faster patient recovery. The 61-year-old patient was admitted after spending over two months bedridden, suffering from end-stage heart failure unresponsive to medical therapy, in addition to multiple chronic conditions including diabetes, stroke, and renal impairment. After a comprehensive clinical evaluation, the patient was deemed ineligible for a heart transplant, making robotic implantation of the artificial pumps a vital and unique solution suited to his health status. This milestone reflects the integration of expertise across multiple departments at KFSHRC including cardiac surgery, cardiology, anesthesia, critical care, biomedical engineering, and advanced life support. The procedure was meticulously planned and benefited from 3D imaging technologies, real-time surgical navigation, and innovative solutions for safely securing the mechanical assist devices. KFSHRC aims to publish the results of this procedure in peer-reviewed medical journals and present them at global cardiology conferences to promote knowledge exchange and establish innovative partnerships with leading international centers in robotic care and advanced heart failure management. This achievement adds to KFSHRC's track record in robotic surgery which includes the world's first fully robotic heart transplant and the World's First Robotic-Assisted Artificial Heart Pump Implantation. These milestones serve as evidence of its leadership in adopting cutting-edge cardiac technologies and managing critical conditions with the highest standards of precision and safety, further reinforcing its position as a leading academic medical center both regionally and globally. It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 20th globally in the list of the world's top 250 Academic Medical Centers for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world's best 250 hospitals and included in the World's Best Smart Hospitals list for 2025 by Newsweek magazine.
Gulf Today
12-07-2025
- Gulf Today
Dermatology campaign to focus on eczema prevention
A genetically-induced skin disease, commonest in boys and women shall be the centrepiece campaign of dermatologists in the UAE and a Saudi-Arabia-headquartered pharmaceutical firm, this academic year until July 2026. The partnership between the Emirates Dermatology Society (EDS) and the Jamjoom Pharma, which has branches in Dubai and Cairo, Egypt, was formalised with the July 4 signing of the Memorandum of Understanding (MoU) in the capital, way ahead of the 'ECZPLORE' September launch. It is 'ECZPLORE' because the campaign is about eczema. EDS president Dr. Ayman Al Naeem told Gulf Today on Friday: 'Eczema has become one of the most pressing skin health issues in the UAE. It affects one in five children and often gets worse, because of the heat, the humidity and the air-conditioning; generally our climate.' Referring to the EDS data, when enquired regarding the youngest and oldest patients, the gender ratio, and the prevalence in the country's multi-racial landscape, Al Naeem said: 'The condition can appear as early as the first few weeks of life, although such an early onset is rare.' Rare too, it is, among septuagenarians and octogenarians who have been found to also be suffering from the disease, which counts 'environmental factors' namely 'allergens, climate, stress and irritants,' particularly those with 'family history and mutations in skin barrier genes like filaggrin,' a protein – a as a cause. These, as in the 'Atopic Dermatitis Insights on Global Prevalence, Health Care Implications and the Impact of COVID-19,' Kyung Hee University College of Medicine (Seoul, South Korea) medical student-researcher Jiyen Oh, noted that by 2050, global incidence would be at 148 million cases 'with minimal change in the prevalence rate.' The research was published in 'The Lancet Respiratory Medicine.' Oh studied the co-relation of eczema, otherwise known as Atopic Dermatitis, with asthma and COVID-19. Oh wrote that the skin disease shall have higher incidences in 'high-income countries likely influenced by environmental factors, urbanisation and better diagnostic capabilities.' Al Naeem pointed out that a campaign is crucial because 'beyond the skin, eczema affects how children sleep, play, learn and interact. For many families, it is a daily emotional and physical struggle.' Jamjoom Pharma-Gulf/Levant/Export Markets general manager Dr. Samer Lezzaiq said they are looking forward at partnerships with relevant authorities and educational institutions even as 'five major schools across the five largest cities in the UAE will be targeted.' 'This campaign is a national call to action designed to reach over one million individuals through digital platforms, schools and on-ground events,' Lezzaiq added, stressing that these are necessary; for, apart from the basic general knowledge, 'guidance on lifestyle modifications' are key to help patients and their households. 'Selection of the five major schools will be randomised. Primary targets are children between two and 12 years old,' said Lezzaiq. He answered in the negative when asked if secondary and tertiary educational institutions were included, as teenagers and young adults may be eczema sufferers as well: 'The age group most affected are the ages two and 12. Secondary schools, colleges, and universities fall outside of the current scope.' From Al Naeem: 'The highest prevalence is typically seen during childhood. In terms of gender distribution, it is more common in boys. This trend shifts in adulthood, with a higher prevalence observed in women.' He repeated Lezzaiq's mention of alterations in lifestyle, pointing out that while 'eczema is not fully preventable, its onset and flare-ups can be significantly reduced' through stress management, early treatment, avoiding triggers, and maintaining a healthy skin barrier with the use of breathable clothing and moisturisers to protect the skin barrier. Other highlights of the MoU, the signing of which was witnessed by EDS vice president Dr. Muna Al Murrawi and EDS-Scientific Committee head Dr. Fatima Albreiki: n The delivery of educational tools which include colouring books to help understand their condition while storybooks foster empathy and hope. n The delivery of lifestyle magazines and quick guides for families, caregivers and other support individuals to complete lifestyle modification among the patients. n The delivery of resources and other materials for healthcare professionals.
